Azaindole derivatives and their use as therapeutic agents
US6476045B2 · kind B2 · utility
8Cited by
2References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2001 |
| Grant date | Nov 5, 2002 |
| Priority date | — |
| Expiry date | Jul 11, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of the formula (I): wherein:Het represents a heterocyclic residue selected from: where the dotted line in (b) represents an optional double bond;A completes a fused pyridine ring; andB completes a fused benzene or pyridine ring.The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migaine, emesis or postherpetic neuralgia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.